Medullary sponge kidney is a condition in which the tiny collecting tubes deep inside the kidney are abnormally dilated, creating small cyst-like spaces that trap minerals and become a factory for kidney stones. It affects roughly 12% of people who form stones repeatedly, though many individuals with the condition never know they have it until imaging reveals the telltale pattern of calcification in the kidney’s inner tissue.1PubMed. Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity The condition is present from birth and does not go away, but its consequences range from zero symptoms to chronic pain, recurrent infections, and metabolic complications that reach well beyond the kidneys.
What Happens Inside the Kidney
In a healthy kidney, urine flows through progressively larger tubes toward the renal pelvis and then down to the bladder. In medullary sponge kidney, the innermost collecting ducts in the kidney’s papillae (the cone-shaped tips that drain into the pelvis) are widened and sometimes frankly cystic. Biopsies show that affected papillae look enlarged and billowy, with markedly dilated inner medullary collecting ducts containing small, mobile stones. The openings of the larger Bellini ducts at the tip of each papilla are also frequently dilated, sometimes plugged with mineral deposits.2PubMed Central. Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation
These dilated pockets act as stagnant pools where calcium and other minerals settle out of the urine and crystallize. The stones that form tend to be small, but they can migrate, cause obstruction, and trigger the intense flank pain known as renal colic. Stone formation is not the only problem, though. The structural abnormality sits at the center of a broader metabolic disturbance that affects acid-base balance, calcium handling, and even bone strength.
The Metabolic Chain Reaction
A key piece of the puzzle is that many people with medullary sponge kidney have a subtle defect in how the distal part of the kidney tubule handles acid. The kidney is supposed to dump acid into the urine to keep blood pH in its narrow safe range. When this process falters, even slightly, it sets off a cascade: the body pulls calcium from bone to buffer the extra acid, calcium spills into the urine in abnormally high amounts, and citrate, which normally keeps calcium dissolved, drops to low levels. The combination of high urinary calcium and low citrate is essentially a recipe for stone formation.3Nephrology Dialysis Transplantation. Medullary sponge kidney: state of the art
This incomplete form of distal renal tubular acidosis shows up in a substantial minority of patients. Estimates suggest somewhere around 30 to 40% of people with MSK have it.4Journal of Case Reports. Medullary Sponge Kidney with Incomplete Renal Tubular Acidosis: A Poorly Understood Disease Studies of women with bilateral MSK found that those with the acidification defect had nearly double the urinary calcium excretion of MSK patients whose acid handling was normal, and dramatically lower citrate levels.5PubMed. Urinary acidification and urinary excretion of calcium and citrate in women with bilateral medullary sponge kidney The degree of the acidification problem correlated directly with how much calcium ended up in the urine and inversely with citrate, suggesting the acid defect is genuinely driving the stone-forming chemistry rather than merely coexisting with it.
Symptoms People Actually Experience
The range of experiences with MSK is wide. Some people are diagnosed incidentally when imaging done for another reason reveals the characteristic pattern of calcification in the renal pyramids. Others deal with recurrent kidney stones, blood in the urine, or repeated urinary tract infections.6SpringerLink / International Urology and Nephrology. Porous perspectives: a comprehensive review of medullary sponge kidney The classic triad that textbooks associate with MSK is nephrocalcinosis (calcium deposits visible in the kidney tissue), hematuria, and renal colic, often accompanied by episodes of kidney infection.7PubMed. Chronic pain in medullary sponge kidney: a rare and never described clinical presentation
What often gets overlooked is chronic pain that persists even when no stone is actively moving. Many patients describe a deep, steady ache in the flank or back that does not come and go with stone episodes. This pain can be severe and life-altering, and its cause is not well understood. It may be independent of urinary obstruction entirely, raising the possibility that the dilated, abnormal tissue itself generates discomfort through nerve irritation or local inflammation. There are essentially no well-designed studies evaluating how to manage this particular pain syndrome, which leaves patients and clinicians improvising with general pain strategies.8PubMed. Medullary sponge kidney and chronic pain: is there a role for renal denervation
The Bone Connection
Because the acidification defect drives calcium out of bone and into urine, people with MSK are at risk of reduced bone density. This is not a theoretical concern. Studies have found that MSK patients with the acid-handling problem have measurably lower bone density than healthy controls. The good news is that treatment with oral potassium citrate, which addresses both the acid imbalance and the low citrate, improved bone density significantly in treated groups.9PubMed Central. Bone disease in medullary sponge kidney and effect of potassium citrate treatment
This finding matters because MSK is usually thought of as a kidney-stone disease, and bone health rarely comes up in initial conversations between patients and doctors. If you have MSK and are being followed for stones but nobody has checked your bone density, that is worth asking about. The metabolic chain that produces stones is the same chain that weakens bone, and both can be addressed simultaneously.
Potassium Citrate and Stone Prevention
Potassium citrate is the closest thing MSK has to a targeted treatment. It works on multiple fronts at once: it supplies citrate (the molecule that keeps calcium dissolved in urine), it provides an alkaline load that helps correct the acidification defect, and it reduces the calcium burden on the kidneys. Long-term data suggest it reduces stone recurrence in MSK patients and, as noted, helps bone density.10PubMed Central. Long-term treatment with potassium citrate and renal stones in medullary sponge kidney
Standard advice for any stone former applies here too: high fluid intake to keep urine dilute, moderate sodium intake, and adequate dietary calcium (restricting calcium can paradoxically increase stone risk by allowing more oxalate to be absorbed from the gut). But in MSK the metabolic driver is specific enough that citrate supplementation has a physiological rationale beyond the generic “drink more water” counsel.
When Stones Need More Than Prevention
Despite preventive efforts, some MSK patients accumulate large or complex stone burdens that require intervention. Shock-wave lithotripsy, which breaks stones from outside the body, is sometimes used, but the diffuse nature of MSK stones, scattered through multiple dilated ducts, can make it less effective than in patients who have a single discrete stone. Minimally invasive percutaneous approaches, in which a small tract is created through the back into the kidney, have been studied specifically in MSK patients. One series achieved a final stone-free rate of about 87% after initial clearance and follow-up procedures, with only low-grade complications and no major adverse events.11PubMed. Safety and efficacy of minimally invasive percutaneous nephrolithotomy in the treatment of patients with medullary sponge kidney These numbers are reassuring, though it is worth noting that the initial clearance rate was lower (around 60%), reflecting the challenge of clearing stones lodged in multiple dilated pockets in a single session.
Is It Inherited?
For a long time, MSK was considered a sporadic condition, essentially a developmental accident with no clear hereditary pattern. That picture has changed. Family studies found that MSK clusters in families in a pattern consistent with autosomal dominant inheritance, meaning a single copy of an affected gene from one parent can produce the condition. But the penetrance is reduced and the expressivity is variable, which in plain terms means not everyone who carries the genetic predisposition develops obvious disease, and among those who do, the severity varies widely.12PubMed. Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity
Researchers have identified specific genetic variants that may play a role. Two previously unknown variants in the GDNF gene were found in a group of MSK patients. GDNF is involved in kidney and urinary tract development. Five of the eight patients carrying these variants had familial MSK, and the variants appeared to track with the disease in a seemingly dominant pattern.13PubMed Central. Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease This does not mean the GDNF variants account for all or even most cases. MSK is likely genetically heterogeneous, with different families carrying different predispositions. But the finding established that at least some cases have a clear genetic basis rather than arising at random.
Diagnosis and Why It Can Be Tricky
The traditional gold standard for diagnosing MSK was intravenous urography (also called an IVP), an X-ray study in which contrast dye is injected and then imaged as the kidneys filter it. The dilated collecting ducts fill with dye and create a characteristic “paintbrush” or “bouquet of flowers” appearance on the images. The problem is that IVP has largely been replaced by CT scanning in modern practice, and standard CT protocols do not always capture the same pattern clearly. A CT without contrast can show the scattered calcifications but may not reveal the dilated ducts themselves.
This shift in imaging technology has led some researchers to argue that MSK is both underdiagnosed and misdiagnosed. A person with recurrent calcium stones and scattered nephrocalcinosis on CT could easily be labeled simply as a stone former without anyone recognizing the underlying structural abnormality. That matters because the treatment approach differs: generic stone-prevention advice misses the metabolic specifics of MSK, and the chronic pain component can go unrecognized if the diagnosis is never made.
Ultrasound can also provide clues. In the kidney’s pyramids, the calcifications appear as bright, echogenic areas. In children, this is sometimes the first hint that something is going on, since pediatric imaging tends to start with ultrasound rather than CT.14PubMed. Medullary sponge kidney in childhood
MSK in Children
Although MSK is usually diagnosed in adults, the condition is congenital and can show up in childhood. Case series have documented MSK in children as young as two. The presenting symptoms tend to be blood in the urine or difficulty concentrating the urine, rather than the classic renal colic seen in adults. Kidney function and size are typically normal, and the diagnosis can be confirmed using the same criteria established in adults.15PubMed. Medullary sponge kidney in childhood
Occasionally, pediatric cases reveal more complex metabolic involvement. One reported case in a five-year-old girl showed features of both distal tubular acidosis and dysfunction of the proximal tubule, with abnormally high uric acid excretion, impaired phosphate handling, and protein spillage into the urine.16PubMed. Medullary sponge kidney associated with distal renal tubular acidosis in a 5-year-old girl Whether this represents an overlap with a separate tubular disorder or an unusually broad expression of the MSK defect is unclear. Either way, it is a reminder that MSK in children can present with metabolic findings beyond the expected pattern.
Long-Term Kidney Function
One of the most common worries people have after an MSK diagnosis is whether the condition will eventually destroy their kidneys. The evidence here is largely reassuring. MSK does not typically cause progressive loss of kidney function. While recurrent infections and stone episodes can theoretically damage kidney tissue over time, the condition itself is not a progressive inflammatory or fibrotic disease like many other chronic kidney disorders.
A telling piece of evidence comes from studies of kidney donors with MSK. When someone with MSK donates a kidney, their remaining kidney shows a recovery pattern essentially identical to that of donors without MSK. At five years after donation, there was no significant difference in kidney filtration rates between MSK donors and non-MSK donors, and none of the MSK donors needed dialysis over a median follow-up of more than eight years.17Clinical Kidney Journal. Outcomes of living kidney donors with medullary sponge kidney If MSK posed a serious threat to long-term kidney function, you would expect someone down to one affected kidney to fare noticeably worse, and they do not.
Living with MSK and Quality of Life
The clinical literature tends to frame MSK as a relatively benign condition, and for many patients it is. But that framing does not always match the lived experience. Qualitative research drawing on MSK support communities found that quality of life, for many patients, is defined by the ability to participate in valued daily activities, and that the unpredictability of stone episodes, chronic pain, fatigue, and repeated infections can significantly erode that participation.18American Journal of Occupational Therapy. Medullary Sponge Kidney: Patients’ Perspectives of Quality of Life and Occupation
Part of the frustration is the gap between the condition’s reputation and its impact. Because MSK is classified as benign and because kidney function stays normal, patients sometimes feel their symptoms are dismissed. The chronic pain in particular falls into a medical blind spot: it does not fit neatly into the stone-pain category (which should resolve when the stone passes), and the lack of published treatment studies means there are no guidelines to follow. Renal denervation, a technique that interrupts the nerve signals from the kidney, has been explored in other pain conditions, but there are essentially no studies of it in MSK specifically, highlighting how little research attention the pain aspect receives.19PubMed. Medullary sponge kidney and chronic pain: is there a role for renal denervation
How It Was First Recognized
MSK has an interesting origin story. It was first identified in 1939 by an Italian radiologist named G. Lenarduzzi, and its thorough clinical description came from a collaboration between Lenarduzzi, a urologist named Cacchi, and a pathologist named Ricci, all working at the University Hospital in Padua. The condition is still sometimes called Cacchi-Ricci disease in European literature.20PubMed. Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s The interdisciplinary nature of the original description, requiring a radiologist to see the pattern, a urologist to understand its clinical significance, and a pathologist to examine the tissue, mirrors the multidisciplinary approach that MSK still demands today. No single specialty owns the condition, which may be part of why it sometimes slips through the cracks.
Conditions That Can Be Confused with MSK
Several other kidney conditions produce cysts, calcifications, or recurrent stones and can overlap with MSK on imaging. Polycystic kidney disease involves far larger cysts that arise throughout the kidney cortex and medulla and causes progressive kidney enlargement and loss of function, features MSK does not share. Nephrocalcinosis from other metabolic causes, such as primary hyperparathyroidism or sarcoidosis, can mimic the calcification pattern but lacks the ductal dilation that defines MSK. Autosomal dominant tubulointerstitial kidney disease causes progressive kidney failure without the stone and cyst pattern of MSK.
The most important practical distinction is between MSK and ordinary idiopathic calcium stone disease. A person forming recurrent calcium stones who has scattered medullary calcification on CT might carry either diagnosis, and the distinction matters for management. If the underlying problem is MSK with an acidification defect, alkali therapy with potassium citrate has a specific physiological rationale. If it is idiopathic calcium stones without an underlying structural abnormality, the treatment choices may differ. Getting the imaging right, ideally with a study that can show the dilated ducts and not just the calcification, is what separates the two.